Reimbursement and coverage risk
Personal Health demand depends on insurance coverage beyond CMS and broader indications of use.
- Scope
- Ekso Indego Personal
- Materiality
- high
EKSO BIONICS HOLDINGS, INC.
Ekso Bionics Holdings, Inc. designs and markets wearable robotic exoskeletons that help people regain mobility in rehabilitation settings and support workers in industrial environments. The company’s core business centers on the EksoNR and Ekso Indego product families, plus related services such as training, maintenance, and extended warranty support.
50
1.63
0.98
| % | |
|---|---|
| Enterprise Health exoskeletons | 70% Clinical robotic exoskeletons used in rehabilitation settings for gait training and mobility support. |
| Personal Health exoskeletons | 15% Devices sold to individual users for personal mobility and home use, supported by reimbursement efforts. |
| Industrial exoskeletons | 5% EVO products sold to commercial and industrial customers to reduce ergonomic strain and improve productivity. |
| Services and support | 10% EksoCare, repairs, maintenance, loaner devices, and training tied to installed devices. |
Ekso sells primarily to healthcare providers that use its devices in rehabilitation programs, especially inpatient...
- Inpatient rehabilitation facilitiesprimary
Buy EksoNR and Ekso Indego Therapy for supervised neurorehabilitation and gait training.
- Integrated delivery networksprimary
Purchase multiple units across hospital networks to standardize rehab programs and improve economics.
- Personal Health userssecondary
Buy Ekso Indego Personal for individual mobility support, often dependent on reimbursement coverage.
- Industrial and commercial employerssecondary
Buy EVO to address ergonomic challenges, especially overhead and repetitive work tasks.
- Distributors and finance partnerssecondary
Enable indirect sales, subscription financing, and broader geographic reach.
Ekso operates across the Americas, EMEA, and APAC, with direct sales strongest in the Americas and a mix of direct and...
- •Americas sales are primarily direct and are a key growth region
- •EMEA uses a mix of direct and distributor channels
- •German-speaking EMEA countries are handled directly
- •APAC is served through direct and indirect channels by country
- •EMEA weakness hurt recent revenue, while Americas offset part of it
Ekso is focused on expanding reimbursement and clinical adoption for its Personal Health products while continuing to...
01
Expand reimbursement for Personal Healthshort-term
Coverage by more insurers would widen the addressable market and reduce reliance on limited CMS reimbursement.
02
Deepen enterprise clinical adoptionmedium-term
Winning larger rehab networks can improve pipeline visibility and lower selling costs through multi-unit deployments.
03
Expand product portfolio with complementary offeringsmedium-term
New products can increase wallet share and create cross-selling opportunities in existing customer accounts.
04
Evaluate strategic alternativesshort-term
A strategic transaction could reshape the company’s capital structure, ownership, or business mix.
Ekso depends on adoption in a specialized healthcare market, reimbursement progress, and continued access to capital,...
Clinical adoption and market acceptance
Hospitals and rehab networks must see clear clinical and economic value before buying multi-unit systems.
- Scope
- Enterprise Health
- Materiality
- high
Manufacturing cost and supply execution
The company has not yet significantly reduced manufacturing cost, which can limit gross margin improvement.
- Scope
- All hardware products
- Materiality
- high
Strategic transaction uncertainty
The company is exploring transactions that could involve a sale of the business or major dilution.
- Scope
- Corporate structure and equity holders
- Materiality
- high
Cybersecurity and data protection
Devices and portals process sensitive patient and proprietary data, creating breach and disruption risk.
- Scope
- EksoPulse and connected services
- Materiality
- medium
Revenue recognition and standalone selling prices
Can shift revenue between periods and affect gross margin comparability
Warrant liabilities fair value
Can create volatile non-cash earnings swings
Inventory valuation
Directly affects gross profit and inventory write-down risk
Warranty and service reserves
Affects operating expense and liability estimates
Deferred tax asset recoverability
Can materially affect balance sheet valuation allowances
: 28.4.2026